Growth Metrics

Nexgel (NXGL) Interest & Investment Income (2023 - 2025)

Nexgel posted quarterly Interest & Investment Income of $10000.0 for Q3 2025, up 150.0% year-on-year from $4000.0 in Q3 2024, and up 147.62% on a QoQ basis from -$21000.0 in Q2 2025.

Nexgel (NXGL) has 3 years of Interest & Investment Income data on file, last reported at $10000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn -
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn 9.00 Mn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn 12.29 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn 5.10 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn -62.00 Mn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn -
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn 3.91 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn -66.00 Mn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn 3.64 Mn
10 Nexgel 31,199.58 -1.34 Mn 819,000.00 -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2025 10,000.00
Jun 30, 2025 -21,000.00
Mar 31, 2025 -21,000.00
Sep 30, 2024 -20,000.00
Jun 30, 2024 -29,000.00
Mar 31, 2024 -15,000.00
Sep 30, 2023 1,000.00
Jun 30, 2023 2,000.00